Provider Misinterpretation, Documentation, and Follow-Up of Definitive Urine Drug Testing Results.

ABSTRACT:

Background

Urine drug testing (UDT) is an essential tool to monitor opioid misuse among patients on chronic opioid therapy. Inaccurate interpretation of UDT can have deleterious consequences. Providers' ability to accurately interpret and document UDT, particularly definitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) results, has not been widely studied.

Objective

To examine whether providers correctly interpret, document, and communicate LC-MS/MS UDT results.

Design

This is a retrospective chart review of 160 UDT results (80 aberrant; 80 non-aberrant) between August 2017 and February 2018 from 5 ambulatory clinics (3 primary care, 1 oncology, 1 pain management). Aberrant results were classified into one or more of the following categories: illicit dru

SUBMITTER: Chua I 

PROVIDER: S-EPMC6957646 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature